心血管機器市場：動向、機会、競合分析

世界の心血管機器市場は2030年までに推定1,158億米ドルに達し、2024～2030年のCAGRは4.8%で成長すると予測されています。市場成長の主要促進要因は、低侵襲手術の需要拡大、医療支出の増加、高齢者人口の増加です。

心血管機器産業の力学に直接的な影響を与える新たな動向としては、ポータブル心臓モニタリング機器の需要増加、経カテーテル大動脈弁置換術（TAVR）の採用増加、生体吸収性ステントの使用増加などが挙げられます。

この調査には、2028年までの世界の心血管機器市場規模と予測を、タイプ別、機器別、地域別に以下のように区分して掲載しています。

この市場でプロファイリングされている心血管機器企業には、Medtronic Public Limited Company、Boston Scientific Corporation、Abbott Laboratories、Edwards Lifesciences Corporation、Johnson &Johnsonなどがあります。

包括的な調査に基づき、Lucintelは、構造的心臓装置、電気生理学、心臓補助装置、診断＆モニタリング装置セグメントが予測期間中に平均以上の成長を示すと予測しています。

世界の心血管機器市場において、CRMセグメントは引き続き最大規模を維持すると予測されます。主に費用対効果と安全性から除細動器の使用が増加しており、CRM市場の大幅な成長が期待されます。

予測期間中、北米が最大市場であり続けると予想されるが、その主要理由は、この地域に大規模な対象患者プールが存在することと、高度な治療の採用率が高いことです。

本レポートの特徴

• 市場規模・推定：市場規模・推定：世界の心血管機器市場規模を出荷額（Mドル）で推定。
• 動向・予測分析：セグメント別・地域別の市場動向（2018～2023年）と予測（2024～2030年）。
• セグメント別分析：心血管機器の世界市場規模をタイプ別、機器別など様々な用途別に金額・数量出荷額で予測。
• 地域別分析：北米、欧州、アジア＆その他など主要地域別の世界の心血管機器市場内訳。
• 成長機会：心血管系機器市場のさまざまな用途と地域における成長機会の分析。
• 戦略分析：世界の心血管機器市場のM&A、新製品開発、競合情勢を含みます。
• ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは、以下の主要な質問に対応しています。

• Q.1.心血管機器の世界市場において、タイプ別、機器別、地域別で最も有望で高成長の機会は何か？
• Q.2.どの製品セグメントがより速いペースで成長すると考えられますか。
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主要要因は何ですか？心血管機器市場の市場の促進要因・課題・ビジネスリスクは何か？
• Q.5.この心血管機器市場におけるビジネスリスクと競合の脅威は何ですか？
• Q.6.この心血管機器市場における新たな動向とその理由は？
• Q.7.心血管機器市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.心血管機器市場における新たな開発はどのようなもので、どの企業がこれらの開拓をリードしているのでしょうか？
• Q.9.心血管機器市場の主要企業は？主要企業は事業成長のためにどのような戦略的イニシアチブを取っていますか？
• Q.10.この心血管機器市場における競合製品にはどのようなものがあり、製品の代替による市場シェア低下の脅威はどの程度ですか？
• Q.11.過去5年間、心血管機器市場ではどのようなM&Aが行われましたか？

目次

第1章 エグゼクティブサマリー

第2章 市場の背景と分類

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

• マクロ経済の動向と予測
• 世界の心血管機器市場の動向と予測
• タイプ別の世界の心血管機器市場
  • 心臓リズム管理（CRM）
  • 心臓介入装置
  • 末梢血管装置
  • 心臓補助装置
  • 構造的心臓装置
  • 心血管外科
  • 電気生理学
  • 診断と監視機器
• 機器別の世界の心血管機器市場
  • ペースメーカー
  • 除細動器
  • ステント
  • 心臓カテーテル
  • ガイドワイヤー
  • 心臓弁
  • 心電図（ECG）
  • イベントモニター
  • その他

第4章 地域別の市場動向と予測分析

• 地域別の世界の心血管機器市場
• 北米の心血管機器市場
• 欧州の心血管機器市場
• アジア太平洋の心血管機器市場
• その他地域の心血管機器市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 市場シェア分析
• 運用上の統合
• 地理的範囲
• ポーターのファイブフォース分析

第6章 コスト構造分析

• 売上原価
• 販管費
• EBITDAマージン

第7章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の心血管機器市場の成長機会
  • 機器別の世界の心血管機器市場の成長機会
  • 地域別の世界の心血管機器市場の成長機会
• 世界の心血管機器市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の心血管機器市場の能力拡大
  • 世界の心血管機器市場における合併、買収、合弁事業
  • 技術開発

第8章 有力企業の企業プロファイル

• Abbott Laboratories
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Medtronic Public Limited Company
• C. R. Bard, Inc.
• Johnson & Johnson
• St. Jude Medical Inc.
• Cook Medical Inc.
• Terumo Corporation
• Cardinal Health Inc.

The global cardiovascular device market is expected to reach an estimated $115.8 billion by 2030 and it is forecast to grow at a CAGR of 4.8% from 2024 to 2030. The major drivers for market growth are growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.

Emerging trends which have a direct impact on the dynamics of the cardiovascular device industry include increasing demand of portable heart monitoring devices, rising adoption of transcatheter aortic valve replacement (TAVR) procedure, and increasing use of bioresorbable stents.

A total of 112 figures / charts and 84 tables are provided in this 197-page report to help in your business decisions. Sample figures with some insights are shown below.

The study includes the cardiovascular device market size and a forecast for the global cardiovascular device market through 2028, segmented by type, device, and region, as follows:

Cardiovascular Device Market by Type [Value ($ Million) from 2018 to 2030]:

• Cardiac Rhythm Management
• Interventional Cardiac Devices
• Peripheral Vascular Devices
• Cardiac Assist Devices
• Structural Heart Devices
• Cardiovascular Surgery
• Electrophysiology
• Diagnostic & Monitoring Devices

Cardiovascular Device Market by Device [Value ($ Million) from 2018 to 2030]:

• Pacemaker
• Defibrillator
• Stent
• Cardiac Catheter
• Guidewire
• Heart Valve
• ECG
• Event Monitor
• Others

Cardiovascular Device Market by Region [Value ($ Million) from 2018 to 2030]:

• North America
• United States
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• APAC
• Japan
• China
• India
• ROW
• Brazil

Cardiovascular device companies profiled in this market include Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are among the major suppliers of cardiovascular devices.

On the basis of comprehensive research, Lucintel forecasts that the structural heart device, electrophysiology, cardiac assist device, and diagnostic & monitoring device segments are expected to show above average growth during the forecast period.

Within the global cardiovascular device market, the CRM segment is expected to remain the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.

North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.

Some of the features of this report:

• Market size estimates: Global cardiovascular device market size estimation in terms of value ($M) shipment.
• Trend and forecast analysis:Market trend (2018-2023) and forecast (2024-2030) by segments and region.
• Segmentation analysis: Global cardiovascular device market size by various applications such as type, and device in terms of value and volume shipment.
• Regional analysis: Global cardiovascular device market breakdown by key regions such as North America, Europe, and Asia & Rest of World.
• Growth opportunities: Analysis on growth opportunities in different applications and regions of cardiovascular device market.
• Strategic analysis:This includes M&A, new product development, and competitive landscape of global cardiovascular device market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report addresses the following key questions:

• Q.1. What are some of the most promising, high-growth opportunities for global cardiovascular device market by type, which includes cardiac rhythm management, interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices, by device (pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which products segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this cardiovascular device market?
• Q.5. What are the business risks and competitive threats in this cardiovascular device market?
• Q.6. What are the emerging trends in this cardiovascular device market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the cardiovascular device market?
• Q.8. What are the new developments in the cardiovascular device market and which companies are leading these developments?
• Q.9. Who are the major players in this cardiovascular device market? What strategic initiatives are being taken by key companies for business growth?
• Q.10. What are some of the competing products in this cardiovascular device market and how big of a threat do they pose for loss of market share by product substitution?
• Q.11. What M&A activity has occurred in thecardiovascular device market during last 5 years?

Table of Contents

1. Executive Summary

2. Market Background and Classifications

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1: Macroeconomic Trends and Forecast
• 3.2: Global Cardiovascular Device Market Trends and Forecast
• 3.3: Global Cardiovascular Device Market by Type
  • 3.3.1: Cardiac Rhythm Management (CRM)
  • 3.3.2: Interventional Cardiac Devices
  • 3.3.3: Peripheral Vascular Devices
  • 3.3.4: Cardiac Assist Devices
  • 3.3.5: Structural Heart Devices
  • 3.3.6: Cardiovascular Surgery
  • 3.3.7: Electrophysiology
  • 3.3.8: Diagnostic & Monitoring Devices
• 3.4: Global Cardiovascular Device Market by Device
  • 3.4.1: Pacemaker
  • 3.4.2: Defibrillator
  • 3.4.3: Stent
  • 3.4.4: Cardiac Catheter
  • 3.4.5: Guidewire
  • 3.4.6: Heart Valve
  • 3.4.7: Electrocardiogram (ECG)
  • 3.4.8: Event Monitor
  • 3.4.9: Others

4. Market Trends and Forecast Analysis by Region

• 4.1: Global Cardiovascular Device Market by Region
• 4.2: North American Cardiovascular Device Market
  • 4.2.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
  • 4.2.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
  • 4.2.3: The United States Cardiovascular Device Market
• 4.3: European Cardiovascular Device Market
  • 4.3.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
  • 4.3.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
  • 4.3.3: Cardiovascular Device Market of Germany
  • 4.3.4: The French Cardiovascular Device Market
  • 4.3.5: Cardiovascular Device Market of the United Kingdom
  • 4.3.6: The Italian Cardiovascular Device Market
  • 4.3.7: The Spanish Cardiovascular Device Market
• 4.4: APAC Cardiovascular Device Market
  • 4.4.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
  • 4.4.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
  • 4.4.3: Japanese Cardiovascular Device Market
  • 4.4.4: The Chinese Cardiovascular Device Market
  • 4.4.5: Indian Cardiovascular Device Market
• 4.5: ROW Cardiovascular Device Market
  • 4.5.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
  • 4.5.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
  • 4.5.3: Brazilian Cardiovascular Device Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Market Share Analysis
• 5.3: Operational Integration
• 5.4: Geographical Reach
• 5.5: Porter's Five Forces Analysis

6. Cost Structure Analysis

• 6.1: Cost of Goods Sold
• 6.2: SG&A
• 6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

• 7.1: Growth Opportunity Analysis
  • 7.1.1: Growth Opportunities for the Global Cardiovascular Device Market by Type
  • 7.1.2: Growth Opportunities for the Global Cardiovascular Device Market by Device
  • 7.1.3: Growth Opportunities for the Global Cardiovascular Device Market by Region
• 7.2: Emerging Trends in the Global Cardiovascular Device Market
• 7.3: Strategic Analysis
  • 7.3.1: New Product Development
  • 7.3.2: Capacity Expansion of the Global Cardiovascular Device Market
  • 7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiovascular Device Market
  • 7.3.4: Technology Development

8. Company Profiles of Leading Players

• 8.1: Abbott Laboratories
• 8.2: Boston Scientific Corporation
• 8.3: Edwards Lifesciences Corporation
• 8.4: Medtronic Public Limited Company
• 8.5: C. R. Bard, Inc.
• 8.6: Johnson & Johnson
• 8.7: St. Jude Medical Inc.
• 8.8: Cook Medical Inc.
• 8.9: Terumo Corporation
• 8.10: Cardinal Health Inc.